First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases

Different factors, not limited to the lung, influence the progression of ILDs. A “treatable trait” strategy was recently proposed for ILD patients as a precision model of care to improve outcomes. However, no data have been published so far on the prevalence of TTs in ILD. A prospective, observation...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Biomedicines Ročník 12; číslo 5; s. 1047
Hlavní autori:	Amati, Francesco, Stainer, Anna, Maruca, Giacomo, De Santis, Maria, Mangiameli, Giuseppe, Torrisi, Chiara, Bossi, Paola, Polelli, Veronica, Blasi, Francesco, Selmi, Carlo, Marulli, Giuseppe, Balzarini, Luca, Terracciano, Luigi Maria, Gatti, Roberto, Aliberti, Stefano
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland MDPI AG 01.05.2024
Predmet:	Airway management Asthma Cardiology Chronic obstructive pulmonary disease Clinical outcomes Comorbidity Connective tissue diseases Cough Development and progression Emphysema endotypes Genotype & phenotype interstitial lung diseases Kinases Lung diseases Medical prognosis Patients Pharmaceutical industry phenotypes Population studies Precision medicine Quality of life Respiratory diseases Respiratory failure Sarcoidosis treatable traits Treprostinil Germany endotypes treatable traits phenotypes interstitial lung diseases
ISSN:	2227-9059, 2227-9059
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!